Catheter Precision, Inc. (VTAK)

Develops medical devices and solutions for precision cardiac catheterization procedures.

VTAK Stock Quote

Company Report

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, specializes in the design, manufacturing, and distribution of cutting-edge medical technologies tailored for cardiac electrophysiology (EP) applications within the United States. The company's flagship offering is the View into Ventricular Onset System, an advanced non-invasive imaging platform renowned for its 3D cardiac mapping capabilities. This innovative system plays a crucial role in accurately localizing the origins of idiopathic ventricular arrhythmias in patients with structurally normal hearts, significantly enhancing the precision and efficacy of electrophysiology procedures.

In addition to its leading product, Catheter Precision provides the LockeT suture retention device, designed to temporarily secure sutures and assist clinicians in precise suture management and removal. Another pivotal innovation is the Amigo Remote Catheter System, a state-of-the-art robotic arm that functions as a sophisticated catheter control device, facilitating intricate maneuvers during cardiac procedures. The company strategically distributes its products through a network of distribution partners, independent sales agents, and direct sales personnel, ensuring broad accessibility and support across the healthcare industry.

Founded on a commitment to advancing cardiac care through technological innovation, Catheter Precision continues to drive progress in the field of electrophysiology. By leveraging its expertise and collaborative approach, the company aims to further expand its portfolio of advanced medical solutions, addressing critical needs in cardiac intervention and improving patient outcomes through enhanced procedural accuracy and eficiency.

VTAK EPS Chart

VTAK Revenue Chart

Stock Research

SI SLB BMBL CREX TJX DECA LAZR

VTAK Chart

View interactive chart for VTAK

VTAK Profile

VTAK News

Analyst Ratings